Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06864468
Recruiting
Primary Prevention of Obesity in American Indian Youth in Rural Tribal Schools
Not applicable · United States · 1 site
Registry update: 20 Nov 2025
NCT07122531
Recruiting
Recovery With Exogenous Ketones and Antipsychotics
Not applicable · Canada · 1 site
Registry update: 22 May 2026
NCT07053059
Recruiting
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
Phase 2 · United States · 1 site
Registry update: 12 Aug 2026
NCT06977724
Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Phase 1 · France, Netherlands, United States · 11 sites
Registry update: 10 Aug 2026
NCT07155252
Recruiting
Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
Not applicable · United States · 1 site
Registry update: 6 Mar 2026
NCT07155564
Recruiting
Validation of Energy Expenditure Measures Study
Not applicable · Germany · 1 site
Registry update: 14 Sept 2026
NCT07425496
Recruiting
To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.
Not applicable · United States · 1 site
Registry update: 24 Feb 2026
NCT06851715
Recruiting
Improving Quality of Life for Teenagers With Asthma
Not applicable · United Kingdom · 2 sites
Registry update: 5 Jan 2026
NCT06906562
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Phase 2 · United States · 108 sites
Registry update: 17 Feb 2026
NCT06982521
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Ireland, Italy, South Korea, Netherlands, Poland, Portugal, Romania, Singapore, Taiwan, United States · 273 sites
Registry update: 5 Nov 2026
NCT07159282
Recruiting
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Phase 4 · United States · 1 site
Registry update: 11 Feb 2026
NCT06639282
Recruiting
Repurposing Siponimod for Alzheimer's Disease
Phase 2 · United States · 1 site
Registry update: 4 Mar 2026
NCT07203287
Recruiting
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Phase 4 · United States · 1 site
Registry update: 20 Oct 2026
NCT07080619
Recruiting
SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers
Phase 2 · China · 1 site
Registry update: 29 Oct 2026
NCT07144800
Recruiting
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Not applicable · United States · 1 site
Registry update: 10 Nov 2026
NCT07131514
Recruiting
HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
Phase 2 · China · 1 site
Registry update: 27 May 2026
NCT05977218
Recruiting
DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
Not applicable · Sweden · 1 site
Registry update: 25 Sept 2025
NCT06968611
Recruiting
Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side
Not applicable · Bangladesh · 2 sites
Registry update: 22 Oct 2026
NCT06662058
Recruiting
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Not applicable · United States · 1 site
Registry update: 16 Jul 2026
NCT06923280
Recruiting
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
Not applicable · China · 2 sites
Registry update: 29 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.